Dietmar Hess holds a degree in biology and has considerable experience in the field of neurophysiology and pharmacology, both in academia and industry. He currently heads the Safety Pharmacology Unit at the NMI TT GmbH (Germany) which focuses on cardiac in vitro and ex vivo models and assays.
The NMI TT GmbH is a GLP/GMP certified contract R&D company, providing dedicated and expert services to customers in the pharmaceutical, biotechnical and medical technology industry.
The facilities at the NMI TT Pharmaservices division encompass electrophysiological assays for preclinical drug development and safety pharmacology, including automated approaches and/or proprietary microelectrode array (MEA)-based technology. Our range extends from single-cell models to the ex vivo level.